New therapies in systemic lupus erythematosus
- 30 April 2002
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Rheumatology
- Vol. 16 (2), 293-312
- https://doi.org/10.1053/berh.2001.0227
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- The immune tolerance network and rheumatic disease: Immune tolerance comes to the clinicArthritis & Rheumatism, 2001
- Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr miceImmunology, 2000
- How to improve morbidity and mortality in systemic lupus erythematosusRheumatology, 2000
- Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transferJournal of Autoimmunity, 1998
- New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulationAnnals Of The Rheumatic Diseases, 1997
- Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential usesJournal of the American Academy of Dermatology, 1996
- Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.JCI Insight, 1996
- Guidelines of care for cutaneous lupus erythematosusJournal of the American Academy of Dermatology, 1996
- Treatment of Murine Lupus with CTLA4IgScience, 1994
- An open study of dehydroepiandrosterone in systemic lupus erythematosusArthritis & Rheumatism, 1994